0
USD
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Pompe Disease - Epidemiology Forecast to 2028
Published Date: April 2019
|
Report Code: DELV-Epid-348
Home | Market Reports |Health |Health Conditions
Pompe Disease Epidemiology Forecast to 2028

Pompe Disease - Epidemiology Forecast to 2028

Code: DELV-Epid-348
Report
April 2019
50 Pages
Delveinsight
Region: Global,
Description
Table of Content
Tables & Figures

DelveInsight's "Pompe Disease - Epidemiology Forecast, 2028” report provides a comprehensive analysis of the Pompe Disease epidemiology, providing the historical and forecasted data for the 7MM during the forecast period from 2016-2028.

Markets Covered
• United States
• EU5 (Germany, France, Italy, Spain, and the United Kingdom)
• Japan

Study Period: 2016-2028

Pompe Disease Epidemiology
The epidemiology section covers the historical, current as well as forecasted epidemiology for Pompe Disease in 7 major markets. The data is collected by understanding the disease, reviewing numerous studies conducted by countries and by exploring different surveys as well as reports. The Key opinion leaders’ views are also taken into account to provide a deep understanding of the Pompe Disease outlook. It also includes the explanation of changing trends of epidemiology outlining the Pompe Disease scenario.

Pompe Disease Epidemiology Segmentation
The epidemiology section is further segmented according to the patient pool characteristics, such as age-specific, type-specific, sub-type specific, gender-specific etc., thus providing an in-depth and high-quality analysis. The report also covers the prevalent/Incidence cases as well as the treatable cases as per the therapies available for the Pompe Disease thereby presenting the trends with detailed analysis, with the assumptions undertaken. The data is presented in the form of graphs along with tables to effectively summarize the landscape.

Report Scope
• The report covers detailed overview of Pompe Disease explaining its causes, symptoms, classification, pathophysiology, diagnosis and treatment patterns
• It provides the insight about the historical and forecasted patient pool for 7 major markets covering the United States, EU5 (Germany, Spain, France, Italy, UK) & Japan
• The Pompe Disease Report assesses the disease risk and burden and highlights the unmet needs
• It also helps to recognize the growth opportunities in the 7MM with respect to the patient population

Key strengths
• 10 Year Forecast
• 7MM Coverage
• Total Cases in Pompe Disease

Key assessments
• Patient Segmentation in Pompe Disease
• Pompe Disease Risk & Burden
• Factors driving growth in a specific Pompe Disease patient population

1. Report Introduction
2. Pompe Disease Epidemiology Overview at a Glance
2.1. Patient Share Distribution of Pompe Disease in 2016
2.2. Patient Share Distribution of Pompe Disease in 2028
3. Disease Background and Overview: Pompe Disease
3.1. Introduction
3.2. Symptoms
3.3. Etiology
3.4. Risk Factors
3.5. Pathophysiology
3.6. Diagnosis
3.7. Treatment
4. Epidemiology and Patient Population
4.1. Key Findings
4.2. Total Prevalent/ Incident Patient Population of Pompe Disease in 7MM
4.3. Total Prevalent/ Incident Patient Population of Pompe Disease in 7MM – By Countries
5. Epidemiology of Pompe Disease by Countries
5.1. United States
5.1.1. Assumptions and Rationale
5.1.2. Prevalent/Incident Cases of the Pompe Disease
5.1.3. Sub-Type Specific cases of the Pompe Disease *
5.1.4. Sex- Specific Cases of the Pompe Disease *
5.1.5. Diagnosed Cases of the Pompe Disease
5.2. EU5
5.3. Assumptions and Rationale
5.4. Germany
5.4.1. Assumptions and Rationale
5.4.2. Prevalent/Incident Cases of the Pompe Disease
5.4.3. Sub-Type Specific cases of the Pompe Disease *
5.4.4. Sex- Specific Cases of the Pompe Disease *
5.4.5. Diagnosed Cases of the Pompe Disease
5.5. France
5.5.1. Assumptions and Rationale
5.5.2. Prevalent/Incident Cases of the Pompe Disease
5.5.3. Sub-Type Specific cases of the Pompe Disease *
5.5.4. Sex- Specific Cases of the Pompe Disease *
5.5.5. Diagnosed Cases of the Pompe Disease
5.6. Italy
5.6.1. Assumptions and Rationale
5.6.2. Prevalent/Incident Cases of the Pompe Disease
5.6.3. Sub-Type Specific cases of the Pompe Disease *
5.6.4. Sex- Specific Cases of the Pompe Disease *
5.6.5. Diagnosed Cases of the Pompe Disease
5.7. Spain
5.7.1. Assumptions and Rationale
5.7.2. Prevalent/Incident Cases of the Pompe Disease
5.7.3. Sub-Type Specific cases of the Pompe Disease *
5.7.4. Sex- Specific Cases of the Pompe Disease *
5.7.5. Diagnosed Cases of the Pompe Disease
5.8. United Kingdom
5.8.1. Assumptions and Rationale
5.8.2. Prevalent/Incident Cases of the Pompe Disease
5.8.3. Sub-Type Specific cases of the Pompe Disease *
5.8.4. Sex- Specific Cases of the Pompe Disease *
5.8.5. Diagnosed Cases of the Pompe Disease
5.9. Japan
5.9.1. Assumptions and Rationale
5.9.2. Prevalent/Incident Cases of the Pompe Disease
5.9.3. Sub-Type Specific cases of the Pompe Disease *
5.9.4. Sex- Specific Cases of the Pompe Disease *
5.9.5. Diagnosed Cases of the Pompe Disease
6. Unmet Needs of the Pompe Disease
7. Appendix
8. Report Methodology
8.1. Sources
9. DelveInsight Capabilities
10. Disclaimer
11. About DelveInsight
*Indication Specific

List of Tables :

Table 1: Total Prevalent/Incident Cases of the Pompe Disease in 7MM
Table 2: Total Prevalent/Incident Cases of the Pompe Disease in 7MM by Countries
Table 3: Prevalent/Incident Cases of the Pompe Disease in United States (2016-2028)
Table 4: Sub-Type Specific cases of the Pompe Disease in United States (2016-2028)*
Table 5: Sex- Specific Cases of the Pompe Disease in United States (2016-2028)*
Table 6: Diagnosed Cases of the Pompe Disease in United States (2016-2028)
Table 7: Prevalent/Incident Cases of the Pompe Disease in Germany (2016-2028)
Table 8: Sub-Type Specific cases of the Pompe Disease in Germany (2016-2028) *
Table 9: Sex- Specific Cases of the Pompe Disease in Germany (2016-2028) *
Table 10: Diagnosed Cases of the Pompe Disease in Germany (2016-2028)
Table 11: Prevalent/Incident Cases of the Pompe Disease in France (2016-2028)
Table 12: Sub-Type Specific cases of the Pompe Disease in France (2016-2028) *
Table 13: Sex- Specific Cases of the Pompe Disease in France (2016-2028) *
Table 14: Diagnosed Cases of the Pompe Disease in France (2016-2028)
Table 15: Prevalent/Incident Cases of the Pompe Disease in Italy (2016-2028)
Table 16: Sub-Type Specific cases of the Pompe Disease in Italy (2016-2028) *
Table 17: Sex- Specific Cases of the Pompe Disease in Italy (2016-2028) *
Table 18: Diagnosed Cases of the Pompe Disease in Italy (2016-2028)
Table 19: Prevalent/Incident Cases of the Pompe Disease in Spain (2016-2028)
Table 20: Sub-Type Specific cases of the Pompe Disease in Spain (2016-2028) *
Table 21: Sex- Specific Cases of the Pompe Disease in Spain (2016-2028) *
Table 22: Diagnosed Cases of the Pompe Disease in Spain (2016-2028)
Table 23: Prevalent/Incident Cases of the Pompe Disease in UK (2016-2028)
Table 24: Sub-Type Specific cases of the Pompe Disease in UK (2016-2028) *
Table 25: Sex- Specific Cases of the Pompe Disease in UK (2016-2028) *
Table 26: Diagnosed Cases of the Pompe Disease in UK (2016-2028)
Table 27: Prevalent/Incident Cases of the Pompe Disease in Japan (2016-2028)
Table 28: Sub-Type Specific cases of the Pompe Disease in Japan (2016-2028) *
Table 29: Sex- Specific Cases of the Pompe Disease in Japan (2016-2028) *
Table 30: Diagnosed Cases of the Pompe Disease in Japan (2016-2028)

List of Figures :

Figure 1: Total Prevalent/Incident Cases of the Pompe Disease in 7MM
Figure 2: Total Prevalent/Incident Cases of the Pompe Disease in 7MM by Countries
Figure 3: Prevalent/Incident Cases of the Pompe Disease in United States (2016-2028)
Figure 4: Sub-Type Specific cases of the Pompe Disease in United States (2016-2028)*
Figure 5: Sex- Specific Cases of the Pompe Disease in United States (2016-2028)*
Figure 6: Diagnosed Cases of the Pompe Disease in United States (2016-2028)
Figure 7: Prevalent/Incident Cases of the Pompe Disease in Germany (2016-2028)
Figure 8: Sub-Type Specific cases of the Pompe Disease in Germany (2016-2028) *
Figure 9: Sex- Specific Cases of the Pompe Disease in Germany (2016-2028) *
Figure 10: Diagnosed Cases of the Pompe Disease in Germany (2016-2028)
Figure 11: Prevalent/Incident Cases of the Pompe Disease in France (2016-2028)
Figure 12: Sub-Type Specific cases of the Pompe Disease in France (2016-2028) *
Figure 13: Sex- Specific Cases of the Pompe Disease in France (2016-2028) *
Figure 14: Diagnosed Cases of the Pompe Disease in France (2016-2028)
Figure 15: Prevalent/Incident Cases of the Pompe Disease in Italy (2016-2028)
Figure 16: Sub-Type Specific cases of the Pompe Disease in Italy (2016-2028) *
Figure 17: Sex- Specific Cases of the Pompe Disease in Italy (2016-2028) *
Figure 18: Diagnosed Cases of the Pompe Disease in Italy (2016-2028)
Figure 19: Prevalent/Incident Cases of the Pompe Disease in Spain (2016-2028)
Figure 20: Sub-Type Specific cases of the Pompe Disease in Spain (2016-2028) *
Figure 21: Sex- Specific Cases of the Pompe Disease in Spain (2016-2028) *
Figure 22: Diagnosed Cases of the Pompe Disease in Spain (2016-2028)
Figure 23: Prevalent/Incident Cases of the Pompe Disease in UK (2016-2028)
Figure 24: Sub-Type Specific cases of the Pompe Disease in UK (2016-2028) *
Figure 25: Sex- Specific Cases of the Pompe Disease in UK (2016-2028) *
Figure 26: Diagnosed Cases of the Pompe Disease in UK (2016-2028)
Figure 27: Prevalent/Incident Cases of the Pompe Disease in Japan (2016-2028)
Figure 28: Sub-Type Specific cases of the Pompe Disease in Japan (2016-2028) *
Figure 29: Sex- Specific Cases of the Pompe Disease in Japan (2016-2028) *
Figure 30: Diagnosed Cases of the Pompe Disease in Japan (2016-2028)

DelveInsight's "Pompe Disease - Epidemiology Forecast, 2028” report provides a comprehensive analysis of the Pompe Disease epidemiology, providing the historical and forecasted data for the 7MM during the forecast period from 2016-2028.

Markets Covered
• United States
• EU5 (Germany, France, Italy, Spain, and the United Kingdom)
• Japan

Study Period: 2016-2028

Pompe Disease Epidemiology
The epidemiology section covers the historical, current as well as forecasted epidemiology for Pompe Disease in 7 major markets. The data is collected by understanding the disease, reviewing numerous studies conducted by countries and by exploring different surveys as well as reports. The Key opinion leaders’ views are also taken into account to provide a deep understanding of the Pompe Disease outlook. It also includes the explanation of changing trends of epidemiology outlining the Pompe Disease scenario.

Pompe Disease Epidemiology Segmentation
The epidemiology section is further segmented according to the patient pool characteristics, such as age-specific, type-specific, sub-type specific, gender-specific etc., thus providing an in-depth and high-quality analysis. The report also covers the prevalent/Incidence cases as well as the treatable cases as per the therapies available for the Pompe Disease thereby presenting the trends with detailed analysis, with the assumptions undertaken. The data is presented in the form of graphs along with tables to effectively summarize the landscape.

Report Scope
• The report covers detailed overview of Pompe Disease explaining its causes, symptoms, classification, pathophysiology, diagnosis and treatment patterns
• It provides the insight about the historical and forecasted patient pool for 7 major markets covering the United States, EU5 (Germany, Spain, France, Italy, UK) & Japan
• The Pompe Disease Report assesses the disease risk and burden and highlights the unmet needs
• It also helps to recognize the growth opportunities in the 7MM with respect to the patient population

Key strengths
• 10 Year Forecast
• 7MM Coverage
• Total Cases in Pompe Disease

Key assessments
• Patient Segmentation in Pompe Disease
• Pompe Disease Risk & Burden
• Factors driving growth in a specific Pompe Disease patient population

Read More

1. Report Introduction
2. Pompe Disease Epidemiology Overview at a Glance
2.1. Patient Share Distribution of Pompe Disease in 2016
2.2. Patient Share Distribution of Pompe Disease in 2028
3. Disease Background and Overview: Pompe Disease
3.1. Introduction
3.2. Symptoms
3.3. Etiology
3.4. Risk Factors
3.5. Pathophysiology
3.6. Diagnosis
3.7. Treatment
4. Epidemiology and Patient Population
4.1. Key Findings
4.2. Total Prevalent/ Incident Patient Population of Pompe Disease in 7MM
4.3. Total Prevalent/ Incident Patient Population of Pompe Disease in 7MM – By Countries
5. Epidemiology of Pompe Disease by Countries
5.1. United States
5.1.1. Assumptions and Rationale
5.1.2. Prevalent/Incident Cases of the Pompe Disease
5.1.3. Sub-Type Specific cases of the Pompe Disease *
5.1.4. Sex- Specific Cases of the Pompe Disease *
5.1.5. Diagnosed Cases of the Pompe Disease
5.2. EU5
5.3. Assumptions and Rationale
5.4. Germany
5.4.1. Assumptions and Rationale
5.4.2. Prevalent/Incident Cases of the Pompe Disease
5.4.3. Sub-Type Specific cases of the Pompe Disease *
5.4.4. Sex- Specific Cases of the Pompe Disease *
5.4.5. Diagnosed Cases of the Pompe Disease
5.5. France
5.5.1. Assumptions and Rationale
5.5.2. Prevalent/Incident Cases of the Pompe Disease
5.5.3. Sub-Type Specific cases of the Pompe Disease *
5.5.4. Sex- Specific Cases of the Pompe Disease *
5.5.5. Diagnosed Cases of the Pompe Disease
5.6. Italy
5.6.1. Assumptions and Rationale
5.6.2. Prevalent/Incident Cases of the Pompe Disease
5.6.3. Sub-Type Specific cases of the Pompe Disease *
5.6.4. Sex- Specific Cases of the Pompe Disease *
5.6.5. Diagnosed Cases of the Pompe Disease
5.7. Spain
5.7.1. Assumptions and Rationale
5.7.2. Prevalent/Incident Cases of the Pompe Disease
5.7.3. Sub-Type Specific cases of the Pompe Disease *
5.7.4. Sex- Specific Cases of the Pompe Disease *
5.7.5. Diagnosed Cases of the Pompe Disease
5.8. United Kingdom
5.8.1. Assumptions and Rationale
5.8.2. Prevalent/Incident Cases of the Pompe Disease
5.8.3. Sub-Type Specific cases of the Pompe Disease *
5.8.4. Sex- Specific Cases of the Pompe Disease *
5.8.5. Diagnosed Cases of the Pompe Disease
5.9. Japan
5.9.1. Assumptions and Rationale
5.9.2. Prevalent/Incident Cases of the Pompe Disease
5.9.3. Sub-Type Specific cases of the Pompe Disease *
5.9.4. Sex- Specific Cases of the Pompe Disease *
5.9.5. Diagnosed Cases of the Pompe Disease
6. Unmet Needs of the Pompe Disease
7. Appendix
8. Report Methodology
8.1. Sources
9. DelveInsight Capabilities
10. Disclaimer
11. About DelveInsight
*Indication Specific

Read More

List of Tables :

Table 1: Total Prevalent/Incident Cases of the Pompe Disease in 7MM
Table 2: Total Prevalent/Incident Cases of the Pompe Disease in 7MM by Countries
Table 3: Prevalent/Incident Cases of the Pompe Disease in United States (2016-2028)
Table 4: Sub-Type Specific cases of the Pompe Disease in United States (2016-2028)*
Table 5: Sex- Specific Cases of the Pompe Disease in United States (2016-2028)*
Table 6: Diagnosed Cases of the Pompe Disease in United States (2016-2028)
Table 7: Prevalent/Incident Cases of the Pompe Disease in Germany (2016-2028)
Table 8: Sub-Type Specific cases of the Pompe Disease in Germany (2016-2028) *
Table 9: Sex- Specific Cases of the Pompe Disease in Germany (2016-2028) *
Table 10: Diagnosed Cases of the Pompe Disease in Germany (2016-2028)
Table 11: Prevalent/Incident Cases of the Pompe Disease in France (2016-2028)
Table 12: Sub-Type Specific cases of the Pompe Disease in France (2016-2028) *
Table 13: Sex- Specific Cases of the Pompe Disease in France (2016-2028) *
Table 14: Diagnosed Cases of the Pompe Disease in France (2016-2028)
Table 15: Prevalent/Incident Cases of the Pompe Disease in Italy (2016-2028)
Table 16: Sub-Type Specific cases of the Pompe Disease in Italy (2016-2028) *
Table 17: Sex- Specific Cases of the Pompe Disease in Italy (2016-2028) *
Table 18: Diagnosed Cases of the Pompe Disease in Italy (2016-2028)
Table 19: Prevalent/Incident Cases of the Pompe Disease in Spain (2016-2028)
Table 20: Sub-Type Specific cases of the Pompe Disease in Spain (2016-2028) *
Table 21: Sex- Specific Cases of the Pompe Disease in Spain (2016-2028) *
Table 22: Diagnosed Cases of the Pompe Disease in Spain (2016-2028)
Table 23: Prevalent/Incident Cases of the Pompe Disease in UK (2016-2028)
Table 24: Sub-Type Specific cases of the Pompe Disease in UK (2016-2028) *
Table 25: Sex- Specific Cases of the Pompe Disease in UK (2016-2028) *
Table 26: Diagnosed Cases of the Pompe Disease in UK (2016-2028)
Table 27: Prevalent/Incident Cases of the Pompe Disease in Japan (2016-2028)
Table 28: Sub-Type Specific cases of the Pompe Disease in Japan (2016-2028) *
Table 29: Sex- Specific Cases of the Pompe Disease in Japan (2016-2028) *
Table 30: Diagnosed Cases of the Pompe Disease in Japan (2016-2028)

List of Figures :

Figure 1: Total Prevalent/Incident Cases of the Pompe Disease in 7MM
Figure 2: Total Prevalent/Incident Cases of the Pompe Disease in 7MM by Countries
Figure 3: Prevalent/Incident Cases of the Pompe Disease in United States (2016-2028)
Figure 4: Sub-Type Specific cases of the Pompe Disease in United States (2016-2028)*
Figure 5: Sex- Specific Cases of the Pompe Disease in United States (2016-2028)*
Figure 6: Diagnosed Cases of the Pompe Disease in United States (2016-2028)
Figure 7: Prevalent/Incident Cases of the Pompe Disease in Germany (2016-2028)
Figure 8: Sub-Type Specific cases of the Pompe Disease in Germany (2016-2028) *
Figure 9: Sex- Specific Cases of the Pompe Disease in Germany (2016-2028) *
Figure 10: Diagnosed Cases of the Pompe Disease in Germany (2016-2028)
Figure 11: Prevalent/Incident Cases of the Pompe Disease in France (2016-2028)
Figure 12: Sub-Type Specific cases of the Pompe Disease in France (2016-2028) *
Figure 13: Sex- Specific Cases of the Pompe Disease in France (2016-2028) *
Figure 14: Diagnosed Cases of the Pompe Disease in France (2016-2028)
Figure 15: Prevalent/Incident Cases of the Pompe Disease in Italy (2016-2028)
Figure 16: Sub-Type Specific cases of the Pompe Disease in Italy (2016-2028) *
Figure 17: Sex- Specific Cases of the Pompe Disease in Italy (2016-2028) *
Figure 18: Diagnosed Cases of the Pompe Disease in Italy (2016-2028)
Figure 19: Prevalent/Incident Cases of the Pompe Disease in Spain (2016-2028)
Figure 20: Sub-Type Specific cases of the Pompe Disease in Spain (2016-2028) *
Figure 21: Sex- Specific Cases of the Pompe Disease in Spain (2016-2028) *
Figure 22: Diagnosed Cases of the Pompe Disease in Spain (2016-2028)
Figure 23: Prevalent/Incident Cases of the Pompe Disease in UK (2016-2028)
Figure 24: Sub-Type Specific cases of the Pompe Disease in UK (2016-2028) *
Figure 25: Sex- Specific Cases of the Pompe Disease in UK (2016-2028) *
Figure 26: Diagnosed Cases of the Pompe Disease in UK (2016-2028)
Figure 27: Prevalent/Incident Cases of the Pompe Disease in Japan (2016-2028)
Figure 28: Sub-Type Specific cases of the Pompe Disease in Japan (2016-2028) *
Figure 29: Sex- Specific Cases of the Pompe Disease in Japan (2016-2028) *
Figure 30: Diagnosed Cases of the Pompe Disease in Japan (2016-2028)

Read More
SELECT A FORMAT
Added to Cart

Single User

Electronic (PDF)
$3250
This license allows only one user to access the PDF.

Site License

Electronic (PDF)
$6500
This license allows all the users of an enterprise residing in one location to access the PDF

Enterprise License

Electronic (PDF)
$9750
This license allows all the employees of an enterprise to access the PDF.
Add to Cart
Buy Now (10% Discount)
OUR CUSTOMER
Accenture

RELATED REPORTS

Global Early Cancer Screening Tests Market Size Status and Forecast 2021 2027
Global Early Cancer Screening Tests Market Size, Status and Forecast 2021-2027

120 Pages
Type: Report
Code: QYRE-Auto-30U5085
Tue Jun 15 00:00:00 UTC 2021

Add to Cart

Global Quick relief Asthma Drugs Market Size Status and Forecast 2021 2027
Global Quick-relief Asthma Drugs Market Size, Status and Forecast 2021-2027

120 Pages
Type: Report
Code: QYRE-Auto-20G5207
Tue Jun 15 00:00:00 UTC 2021

Add to Cart

Global Bare Metal Coronary Artery Stent Sales Market Report 2021
Global Bare Metal Coronary Artery Stent Sales Market Report 2021

120 Pages
Type: Report
Code: QYRE-Auto-36Z5191
Tue Jun 15 00:00:00 UTC 2021

Add to Cart

Global Pets Pain Relief and Prevention Market Research Report 2021
Global Pets Pain Relief and Prevention Market Research Report 2021

120 Pages
Type: Report
Code: QYRE-Auto-28J2423
Tue Jun 15 00:00:00 UTC 2021

Add to Cart

0 Items
X
No items in the cart.
$0.0